Chapter Summary
This chapter addressed the administrative consequences that could result from a breach of an ethical responsibility to the participants in research or to the institution. It should be noted again that ethical obligations are not invariably coextensive with legal obligations and vice versa. As we saw in chapter 4, the overriding theme is the protection of the research participants and the consequences of a failure to do so. However, it is also clear from the discussion in chapter 5 that there are legally-imposed limits on the extent to which participants may be protected from the disclosure of information about them and/or their behavior.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alaska Statutes § 47.24.010 (1998).
Andrews v. Eli Lilly & Company, 97 F.R.D. 494 (N.D. Ill. 1983).
Application ofAmerican Tobacco Company, 880 F.2d 1520 (2d Cir. 1989).
Application of R.J. Reynolds Tobacco Company, 136 Misc.2d 282,328 N.Y.S. 729 (1987).
Barinaga, M. (1992). Who controls a researcher’s files? Science, 256, 1620–1621.
Brady v. Hopper, 570 F. Supp. 1333 (D. Colo. 1983).
Broad, W. & Wade, N. (1982). Betrayers of the Truth. New York: Simon and Schuster.
California Government Code §§ 6250, 6253, 6254 (West 1995).
Chambers, M. (1986, October 9). Dead Baby’s Mother Faces Criminal Charge on Acts in Pregnancy, N.Y. Times.
Churchville, V. (1988, July 23). D.C. Judge Jails Woman as Protection for Fetus, Washington Post, at Al.
Cobbs v. Grant, 8 Cal. 3d 229 (1972).
Commission on Research Integrity, United States Department of Health and Human Services. (1998). Integrity and Misconduct in Research.
Commonwealth v. Kemp, 643 A.2d 705 (Pa. 1994).
Commonwealth v. Aurick, 19 A.2d 920 (Pa. 1941).
Commonwealth v. Malone, 47 A.2d 445 (Pa. 1946).
Commonwealth v. Pelligrini, No. 87970, slip. op. (Mass. Dist. Ct. Oct. 15, 1990).
Commonwealth v. Welansky, 5 N.E.2d 902 (Mass. 1944).
Connecticut General Statutes Annotated § 17b-450 (West 1998).
Council for International Organizations of Medical Sciences (CIOMS), World Health Organization (WHO). (1993). International Guidelines for Biomedical Research Involving Human Subjects. Geneva: WHO.
Council for International Organizations of Medical Sciences (CIOMS). (1991). International Guidelines for Ethical Review ofEpidemiological Studies. Geneva: Author.
Davis v. Lhim, 124 Mich. App. 291 (1983), affirmed on remand 147 Mich. App. 8 (1985), reversed on grounds of government immunity in Canon v. Thumudo, 430 Mich. 326 (1988).
Deitchman v. E.R. Squibb & Sons, Inc., 740 F.2d 556 (7th Cir. 1984).
Department of Justice v. Tax Analysts, 109 S.Ct. 2841 (1989).
Departmental Appeals Board (DAB) Decision No. 1677 (February 5, 1999).
Director, OPRR. (1997, January 23). Memorandum to OPRR Staffre: Compliance Oversight Procedures. Available at http://www.fda.gov/oc/oha/IRB/toc9.html
Dresser, R. (1993a). Defining scientific misconduct: The relevance of mental state. Journal of the American Medical Association, 269, 895–897.
Dresser, R. (1993b). Sanctions for research misconduct: A legal perspective. Academic Medicine, 68, S39–S43.
Earle v. Kuklo, 26 N.J. Super. 471 (App. Div. 1953).
Farnsworth v. Proctor and Gamble Company, 785 F.2d 1545 (11th Cir. 1985).
Farthing, M.J.G. (1998). An editor’s response to fraudsters. British Medical Journal, 316, 1729–1731.
Federal Rules of Civil Procedure 26(b), 45(b) (1983).
Florida Statute Annotated § 415.102(12) (West 1999).
Florida Statute Annotated § 415.102(22) (West 1999).
Food and Drug Administration (FDA). (1998, September). Information Sheets: Guidance for Institutional Review Boards and Clinical Investigators. 1998 Update. Available at http://www.fda.gov/oc/oha/IRB/toc9.html
Forsham v. Harris, 445 U.S. 169 (1980).
Freedman, B. & Glass, K.C. (1990). Weiss v. Solomon: A case study in institutional responsibility for clinical research. Law, Medicine & Health Care, 18, 395–403.
Friter v. Iolab Corporation, 607 A.2d 1111 (Pa. Super. Ct. 1992).
Gore, A., Jr. (1981). Testimony before the House Subcommittee on Investigations and Oversight of the Committee on Science and Technology. Fraud in Medical Research: Hearings Before the House Subcommittee on the Investigation and Oversight of the Committee on Science and Technology. 97th Congress, 1st Session, 286.
Gray v. Grunnagle, 223 A.2d 663 (Pa. 1966).
Hager, P. (1992, Aug. 22). Murder Charge Rejected in Drug-Related Stillbirth, Los Angeles Times, at Al, col. 5.
Hilts, P.J. (1991, March 22). Hero in exposing science hoax paid dearly. New York Times, AI, B6.
Hilts, P.J. & Stolberg, S.G. (1999, May 13). Ethics lapses at Duke halt dozens of human experiments. New York Times, A26.
Hiserodt v. Shalala, (1994, July 20). C.A. No. 91-0224 (W.D. Pa.), affirmed No. 94-3404 (3d Cir. July 5, 1995). See http://ori.dhhs.gov/legal/htm.
Holder, A.R. (1989). Researchers and subpoenas: The troubling precedent of the Selikoff case. IRB, 11, 8–11.
Holder, A.R. (1993). Research records and subpoenas: A continuing issue. IRB, 15,6–7.
Horne v. Patton, 287 So.2d 824 (Ala. 1974).
Horowitz, A.M. (1996). Fraud and scientific misconduct in the United States. In S. Lock & F. Wells (Eds.). Fraud and Misconduct in Medical Research (2nd ed., pp. 144–165). London: BMJ Publishing Group.
Hoseini v. United States, 541 F. Supp. 999 (D. Md. 1982).
In re Grand Jury Subpoena Dated Jan. 4, 1984, 750 F.2d 223 (2d Cir. 1984).
Jablonski v. United States, 712 F.2d 391 (9th Cir. 1983).
Jacobus, P. (1992, April 2). Prosecutors’ New Drug War Target: The Womb, Los Angeles Daily Journal at 1, col. 2.
John C. Hiserodt, M.D., Ph.D. (1995, February 25). DAB No. 1466.
Johnson v. State, 602 So. 2d 1288 (Fla. 1992).
Kentucky v. Welch, 864 S.W.2d 280 (Ky. 1993).
Kissinger v. Reporters Committee for Freedom of the Press, 445 U.S. 136 (1980).
Kubie, L.S. (1958). Neurotic Distortion of the Creative Process. Lawrence, Kansas: University of Kansas Press.
Kus v. Sherman Hospital, 644 N.E.2d 1214 (Ill. App. 1995).
Kuzma, S.M. (1992). Criminal liability for misconduct in scientific research. University of Michigan Journal of Law Reform, 25, 357–421.
Lamb, D.H., Clark, C., Drumheller, P., Frizzell, K., & Surrey, L. (1989). Applying Tarasoff to AIDS related psychotherapy issues. Professional Psychology: Research and Practice, 20, 37–43.
Leonard v. Latrobe Area Hospital, 625 A.2d 1228 (Pa. Super. Ct. 1993).
Lipari v. Sear, Roebuck & Co., 497 F. Supp. 185 (D. Neb. 1980).
Lock, S. (1996). Research misconduct: A resume of recent events. In S. Lock & F. Wells (Eds.). Fraud and Misconduct in Medical Research (2nd ed., pp. 14–39). London: BMJ Publishing Group.
McBride, G. (1974). The Sloan-Kettering Affair: Could it have happened anywhere? Journal of the American Medical Association, 229, 1391–1410.
McIntosh v. Milano, 168 N.J. Super. 466 (1979).
McTaggart, L. (1980, December 7). Putting drug testers to the test. New York Times, Magazine Section, 174.
Melton, G.B. & Gray, J.N. (1988). Ethical dilemmas in AIDS research: Individual privacy and public health. American Psychologist, 43, 60–64.
Mink v. University of Chicago, 460 F. Sup. 713 (N.D. Ill. 1978).
Mints, M. (1979, June 1). Indictment accuses drug-testing firm of falsifying results. Washington Post, A9.
Moore v. Regents of the University of California, 215 Cal. App. 3d 709 (1988), reversed 51 Cal. 3d 120 (1990).
Needleman v. Shalala, et al. (1996, May 22). C.A. No. 920749 (W.D. Pa.). See http://ori.dhhs.gov/legal/htm.
Nevada Revised Statute § 200.5092 (1987).
Nevada Revised Statute § 200.5093 (1987).
New York Penal Law §125.25 (19_).
Nigg, N.G. & Radulsecu, G. Scientific misconduct in environmental science and toxicology. Journal of the American Medical Association, 272, 168–170.
Nylenna, M., Aderse, D., Dahlquist, G., Sarvas, M., & Aakvaag, A. (1999). Handling of scientific dishonesty in the Nordic countries. Lancet, 354, 57–61.
Office for Protection from Research Risks Review Panel. (199, June 3). Report to the Advisory Committee to the Director, NIH. Available at http://www.nih.gov/welcome/director/060399b.htm.
Office of Research Integrity. (1996). Consequences of being accused of scientific misconduct. In 1996 ORI Annual Report.
Office of Research Integrity. (1995). Annual Report.
Office of Research Integrity. (1996). Annual Report.
Office of Research Integrity. (1994a). Chagnon. 59 Federal Register 38979.
Office of Research Integrity. (1994b). Constantoulakis, 59 Federal Register 45670.
Office of Research Integrity. (1994c). Leisman. 59 Federal Register 64667.
Office of Research Integrity. (1995) 60 Federal Register 66276.
Office of Research Integrity. Model Procedures for Responding to Allegations of Scientific Misconduct. Available at http://ori.dhhs.gov/
Office of Research Integrity. Summaries of Closed Investigations Not Resulting in Findings of Misconduct. Available at http://ori.dhhs.gov/
Office of Research Integrity. (1994d). Suprenant. 59 Federal Register 39366.
Office of Scientific Integrity. (1999, January). Scientific Misconduct Investigations, 1993–1997. Rockville, Maryland: Department of Health and Human Services.
Ohio Revised Code Annotated § 5101.60(K) (Banks-Baldwin 1994).
Ohio Revised Code Annotated § 5101.61(A) (Banks-Baldwin 1994).
ORI Newsletter (1994, December). Available at http://ori.dhhs.gov/definition.htm.
Palca, J. (1992). The case of the Florida dentist Science, 255, 392–394.
Parrish, D.M. (1997). Improving the scientific misconduct hearing process. Journal of the American Medical Association, 277, 1315–1319.
Pennsylvania Statute Annotated, title 35, § 10225.103 (1999).
People v. Hardy, 469 N.W.2d 50 (Mich. App. 1991).
People v. Morabito, (City Ct., Geneva), reported in N.Y.L.J. Feb. 19, 1992, at 30
Public Health Service, United States Department of Health and Human Services. (1987). A Public Health Challenge: State Issues, Policies, and Programs. Vol. 1, pp. 4-1–4-31.
Reinesto v. Superior Court, 894 P.2d 733 (Ariz. App. 1995).
Riis, P. (1006). Creating a national control system on scientific dishonesty within the health sciences. In S. Lock & F. Wells (Eds.). Fraud and Misconduct in Medical Research (2nd ed., pp. 114–127). London: BMJ Publishing Group.
Riis, P. (1994). Prevention and management of fraud—in theory. Journal of Internal Medicine, 235, 107–113.
Rubin, N. (1990, June/July). Motherhood on trial, Parenting, 74.
Ruling on Respondent’s Motion to Dismiss for Lack of Jurisdiction: Notice of Further Procedures,. (1995, Aug. 15). Board Docket No. A-95-123 (Kerr). See http://ori.dhhs.gov/legal.htm.
Shapiro, M.F. & Charrow, R.D. (1985). Special report: Scientific misconduct in investigational drug trials. New England Journal of Medicine, 312,731-_.
Sheriff of Washoe County v. Encoe, 885 P.2d 596 (Nev. 1994).
State v. Gray, 584 N.E.2d 710 (Ohio 1992).
State v. Hefner, 155 S.E. 879 (N.C. 1930).
State v. Kruzicki, 541 N.W.2d482 (Wis. App. 1995)
State v. Luster, 419 S.E.2d 32 (Ga. App. 1992).
Tarasoff v. Regents of the University of California, 551 P.2d 334 (1976).
Texas Human Resources § 48-002 (West Supp. 1999).
Thompson v. County of Alameda, 27 Cal. 3d 741 (1980).
United States v. Breuning, No. K-88-0135 (D. Md. Sept. 18, 1988). Cited in S.M. Kuzma. (1992). Criminal liability for misconduct in scientific research. University of Michigan Journal of Law Reform, 25, 357–385.
United States Department of Health and Human Services. (1993, September). Office of Research Integrity: An Introduction. Rockville, Maryland: United States Department of Health and Human Services.
United States Department of Health and Human Services. (1999, October 22). Promoting integrity in research. HHS Fact Sheet. Available at http://ori.dhhs.gov/991022a.htm.
Van Horn v. Chambers, 970 S.W.2d 542 (Tex. 1998).
Votteler v. Heltsley, 327 N.W.2d 759 (Iowa 1982).
Washington Research Project v. Department of Health, Education & Welfare, 504 F.2d 238 (D.C. Cir. 1974).
Wenger, N.S., Korenman, S.G., Berk, R., & Berry, S. (1997). The ethics of scientific research: An analysis of focus groups of scientists and institutional representatives. Journal of Investigative Medicine, 45, 371–380.
Whither v. State, 65 U.S.L.W. 2066 (S.C. 1996).
Wion, A.H. (1979). The definition of “agency records” under the Freedom of Information Act. Stanford Law Review, 31, 1093–1115.
21 Code of Federal Regulations §§ 50.3,50.25 (1998).
42 Code of Federal Regulations §§ 2a.1–2a.7, 50.102, 50.104 (1999).
45 Code of Federal Regulations §§ 76.110,-.115,-.305,-.311,-.313-.314,-.320,-.400-.413,-.415 (1999).
45 Code ofFederal Regulations § 689.1 (1998).
5 United States Code Annotated §§ 552,552a (West 1996 & Supp. 1999).
5 United States Code § 553 (West Supp. 1996).
18 United States Code §§ 287, 1001, 1341 (West 1999)
18 United States Code § 1505 (West 1998).
21 United States Code Annotated § 872 (West 1999).
42 United States Code Annotated §§ 241,290dd-2 (West 1999).
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
(2002). Legal Issues in Research. In: Textbook of Research Ethics. Springer, Boston, MA. https://doi.org/10.1007/0-306-46839-5_5
Download citation
DOI: https://doi.org/10.1007/0-306-46839-5_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46448-5
Online ISBN: 978-0-306-46839-1
eBook Packages: Springer Book Archive